Under construction – not a live service
Sign in
Taking people in GermanyNo phase

Tests MR-guided radiotherapy machine in several types of cancer

Tests imaging and radiotherapy on a new MR-Linac device in adults with cancer.

Plain-language title generated from the registry record
Registry title: Feasibility of Online MR-guided Radiotherapy on a 1.5T MR-Linac

Key facts

Where
Tübingen, GermanySee the site

Where in Germany

  • University Hospital Tübingen, Department of Radiation OncologyTübingen, GermanyTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University Hospital Tuebingen
Trial code
NCT04172753
Record updated
21 November 2019
Original description
This study investigates the feasibility of imaging and treatment on a novel 1.5 T MR-Linac radiotherapy hybrid device.Read full original descriptionShow less

Feasibility of Imaging and Radiotherapy on a Novel 1.5 T Hybrid Magnetic Resonance Imaging - Linear Accelerator System (MR-Linac)

This study investigates the feasibility of imaging and treatment on a novel 1.5 T MR-Linac radiotherapy hybrid device.

Inclusion: existing indication for radiation therapy; minimum age 18 years, no upper age limit; capacity for consent; Informed consent.

Exclusion: contraindication for MRI (claustrophobia, metallic implants not applicable for MRI; pregnancy.

ClinicalTrials.gov NCT04172753